Victory Capital Management Inc. Has $454,000 Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Victory Capital Management Inc. lifted its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 202.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,298 shares of the company’s stock after purchasing an additional 12,912 shares during the quarter. Victory Capital Management Inc. owned 0.28% of Semler Scientific worth $454,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of SMLR. CWM LLC raised its position in shares of Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in Semler Scientific in the 2nd quarter valued at approximately $34,000. Quest Partners LLC acquired a new stake in Semler Scientific in the 2nd quarter valued at approximately $59,000. Meeder Asset Management Inc. acquired a new stake in Semler Scientific in the 2nd quarter valued at approximately $67,000. Finally, US Bancorp DE raised its position in Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after buying an additional 1,158 shares during the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Performance

Shares of Semler Scientific stock opened at $57.02 on Friday. The business’s 50 day simple moving average is $35.16 and its 200 day simple moving average is $31.74. Semler Scientific, Inc. has a 52-week low of $20.88 and a 52-week high of $79.45. The firm has a market cap of $472.70 million, a PE ratio of 28.10 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The business had revenue of $13.51 million for the quarter.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.